Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience.
| Published in: | Future Oncology Vol. 22; no. 19; pp. 2347 - 2367 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Published: |
Taylor & Francis Ltd
Aug2026
|
| Online Access: | View this record in EBSCOhost |